Intriguingly, SCN3A was identified as a potential marker in patients with chronic thromboembolic pulmonary hypertension, and it is predicted to participate in the ion flux of pulmonary artery smooth muscle cells (PASMC), which modulates excitation and contraction of pulmonary vessels [79]. The gene discussed is SCN3A; the disease is chronic thromboembolic pulmonary hypertension.